Cogstate Ltd has released a press release.
Cogstate selected as preferred provider for Lilly
Filed with ASX ·
Watch Cogstate's latest callCogstate (ASX:CGS) Q4 2026 Earnings Call · Replay · Aug 17Read the transcript of Cogstate (ASX:CGS) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Earlier from Cogstate
- Appendix 4D and Half-Year Financial Report
- Cogstate enters into agreement with Clinical Ink
- 2016 Financial Year Results
- Chairmans Address to Shareholders
- JV Agreement Signed
Later from Cogstate
- FY17 Earnings Update
- Cogstate cleared by FDA to start marketing Cognigram in U.S.
- Interim Business Update
- Global Alzheimer Platform Foundation Selects Cogstate
- Appendix 4D & Half Year Financial Report
Follow Cogstate into a list and get an email when it puts out news.
Follow Cogstate